[ad_1]

The deal is a victory for Trump who has pressured drugmakers to voluntarily comply with his policy priorities. If not, they will likely face regulation or high tariffs.
[ad_2]
Source link
[ad_1]

The deal is a victory for Trump who has pressured drugmakers to voluntarily comply with his policy priorities. If not, they will likely face regulation or high tariffs.
[ad_2]
Source link